Xueting Cai

3.5k citations
83 papers · 2.6k indexed · 1 hit paper · h-index 29
Topics
Genomics, phytochemicals, and oxidative stress (7 papers)Natural product bioactivities and synthesis (7 papers)Cancer Mechanisms and Therapy (6 papers)
Partner nations
ChinaUnited StatesSpain

In The Last Decade

Xueting Cai

80 papers receiving 2.5k citations

Hit Papers

Ginseng-derived nanoparticles alter macrophage polarizati...20192026202120232019100200300

Peers

Xueting Cai
Comparison fields: 5 of 120
  • Molecular Biology 1.5k
  • Cancer Research 400
  • Immunology 378
  • Oncology 341
  • Pharmacology 275
Replace Lan Luo with:
Lan Luo China
Guang Xu China
Seung Hyun Oh South Korea
Xiangchun Shen China
Chi Hin Cho China
Sosmitha Girisa India
Tinghong Ye China
Xuechun Li China
Ji Hye Kim United States
Xueting Cai relative to Lan Luo China Lan Luo's profile →
Citations per field
00.5×1.5×1.8×
Lan Luo · 1×
Citations per year

Countries citing papers authored by Xueting Cai

Since Specialization
Citations

This map shows the geographic impact of Xueting Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueting Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueting Cai more than expected).

Fields of papers citing papers by Xueting Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueting Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueting Cai. The network helps show where Xueting Cai may publish in the future.

Co-authorship network of co-authors of Xueting Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Xueting Cai. A scholar is included among the top collaborators of Xueting Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueting Cai. Xueting Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 0
4 1
5 4
6 27
7 9
8 105
9 14
10 22
11 6
12 52
13 18
14 53
15 37
16 22
17 79
18 35
19 44
20 20

About Xueting Cai

Xueting Cai is a scholar working on Complementary and alternative medicine, Pharmacology and Toxicology, having authored 83 papers that have together received 2.6k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (7 papers), Natural product bioactivities and synthesis (7 papers) and Cancer Mechanisms and Therapy (6 papers). The work is most often cited by research in Pharmacology (275 citations), Cancer Research (400 citations) and Molecular Biology (1.5k citations). Xueting Cai has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Peng Cao, Wuguang Lu, Chunping Hu, Juan Ye, Huaijiang Yan, Xiaolan Cheng, Qingyun Wei, Ling Weng, Meng Cao and Xiaoyan Sun. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026